You are here

antivirals

Merck asks FDA to authorize promising anti-COVID pill

NPR

Mon, 10/11/21 - 10:29 am

Ridgeback Therapeutics

Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?

Motley Fool

Fri, 10/8/21 - 10:58 am

Ridgeback Therapeutics

Atea Pharmaceuticals

Merck May Beat Pfizer to the COVID Pill Market. Does It Matter?

Motley Fool

Wed, 10/6/21 - 10:53 am

Merck says research shows its COVID-19 pill works against variants

Reuters

Thu, 09/30/21 - 11:13 pm

Delta COVID-19 variant

Pfizer starts trial of antiviral pill against COVID-19

Biopharma Reporter

Wed, 09/29/21 - 11:02 am

clinical trials

Antiviral nasal drop maker does the Nasdaq shuffle as part of minor SPAC reverse merger

Endpoints

Tue, 08/31/21 - 11:02 am

Revelation Biosciences

Merck kicks off oral COVID-19 antiviral filing in Canada

Pharmaforum

Mon, 08/16/21 - 11:04 am

Gilead, Foresite back biotech developer of COVID-19 pill in latest SPAC deal

BioPharma Dive

Wed, 06/30/21 - 12:11 am

Gilead Sciences

Pardes Biosciences

White House pledges $3 billion war chest for COVID antivirals

Pharmaforum

Thu, 06/17/21 - 10:47 pm

This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market

Motley Fool

Thu, 06/17/21 - 10:50 am

Ridgeback Biotherapeutics

Romark eyes FDA okay for COVID antiviral despite mixed trial results

Pharmaforum

Thu, 04/15/21 - 10:49 am

clinical trials

Anixa and OntoChem enter next stage of Covid-19 anti-viral therapy development

Pharmaceutical Business Review

Tue, 04/6/21 - 10:08 am

Anixa Biosciences

Pfizer begins clinical trials of COVID-19 antiviral pill

Pharmaforum

Wed, 03/24/21 - 10:06 am

protease inhibitors

Novartis taps Molecular Partners for a new way to defeat COVID-19

Fierce Biotech

Wed, 10/28/20 - 10:33 am

Molecular Partners

BioSig abandons COVID-19 drug trial on safety concerns

Pharmaforum

Tue, 10/27/20 - 10:34 am

BioSig Technologies

clinical trials

Roche joins the COVID-19 antiviral drug race, betting $350M on a startup

BioPharma Dive

Thu, 10/22/20 - 10:51 am

Atea Pharmaceuticals

As Covid research heats up, J&J retires a BARDA-funded flu antiviral they worked on for 7 years

Endpoints

Thu, 09/3/20 - 10:13 am

FDA clears Appili Therapeutics to expand its trial of favipiravir for prrevention of Covid-19

Pharmaceutical Business Review

Tue, 08/11/20 - 12:34 pm

Appili Therapeutics

clinical trials

Gilead Sciences Submits New Drug Application for Remdesivir as a COVID-19 Treatment

Motley Fool

Mon, 08/10/20 - 11:09 pm

Gilead Sciences

Emergency Use Authorization

Merck to Begin Pivotal COVID-19 Antiviral Studies in September

BioSpace

Fri, 07/31/20 - 11:24 pm

clinical trials

Pages